245 related articles for article (PubMed ID: 19448395)
1. Aging-suppressants: cellular senescence (hyperactivation) and its pharmacologic deceleration.
Blagosklonny MV
Cell Cycle; 2009 Jun; 8(12):1883-7. PubMed ID: 19448395
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologic inhibition of MEK and PI-3K converges on the mTOR/S6 pathway to decelerate cellular senescence.
Demidenko ZN; Shtutman M; Blagosklonny MV
Cell Cycle; 2009 Jun; 8(12):1896-900. PubMed ID: 19478560
[TBL] [Abstract][Full Text] [Related]
3. Aging and immortality: quasi-programmed senescence and its pharmacologic inhibition.
Blagosklonny MV
Cell Cycle; 2006 Sep; 5(18):2087-102. PubMed ID: 17012837
[TBL] [Abstract][Full Text] [Related]
4. Forever young, slim and fit: rapamycin to the rescue.
Darzynkiewicz Z
Cell Cycle; 2009 Jun; 8(12):1820-1. PubMed ID: 19471126
[No Abstract] [Full Text] [Related]
5. Increasing healthy lifespan by suppressing aging in our lifetime: preliminary proposal.
Blagosklonny MV
Cell Cycle; 2010 Dec; 9(24):4788-94. PubMed ID: 21150328
[TBL] [Abstract][Full Text] [Related]
6. Rapamycin decelerates cellular senescence.
Demidenko ZN; Zubova SG; Bukreeva EI; Pospelov VA; Pospelova TV; Blagosklonny MV
Cell Cycle; 2009 Jun; 8(12):1888-95. PubMed ID: 19471117
[TBL] [Abstract][Full Text] [Related]
7. At concentrations that inhibit mTOR, resveratrol suppresses cellular senescence.
Demidenko ZN; Blagosklonny MV
Cell Cycle; 2009 Jun; 8(12):1901-4. PubMed ID: 19471118
[TBL] [Abstract][Full Text] [Related]
8. Cell cycle arrest is not yet senescence, which is not just cell cycle arrest: terminology for TOR-driven aging.
Blagosklonny MV
Aging (Albany NY); 2012 Mar; 4(3):159-65. PubMed ID: 22394614
[TBL] [Abstract][Full Text] [Related]
9. Rapamycin, proliferation and geroconversion to senescence.
Blagosklonny MV
Cell Cycle; 2018; 17(24):2655-2665. PubMed ID: 30541374
[TBL] [Abstract][Full Text] [Related]
10. mTOR as Regulator of Lifespan, Aging, and Cellular Senescence: A Mini-Review.
Weichhart T
Gerontology; 2018; 64(2):127-134. PubMed ID: 29190625
[TBL] [Abstract][Full Text] [Related]
11. Rapamycin and the inhibition of the secretory phenotype.
Wang R; Sunchu B; Perez VI
Exp Gerontol; 2017 Aug; 94():89-92. PubMed ID: 28167236
[TBL] [Abstract][Full Text] [Related]
12. Gerosuppressant metformin: less is more.
Menendez JA; Cufí S; Oliveras-Ferraros C; Vellon L; Joven J; Vazquez-Martin A
Aging (Albany NY); 2011 Apr; 3(4):348-62. PubMed ID: 21483040
[No Abstract] [Full Text] [Related]
13. Quantifying pharmacologic suppression of cellular senescence: prevention of cellular hypertrophy versus preservation of proliferative potential.
Demidenko ZN; Blagosklonny MV
Aging (Albany NY); 2009 Dec; 1(12):1008-16. PubMed ID: 20157583
[TBL] [Abstract][Full Text] [Related]
14. Yeast-like chronological senescence in mammalian cells: phenomenon, mechanism and pharmacological suppression.
Leontieva OV; Blagosklonny MV
Aging (Albany NY); 2011 Nov; 3(11):1078-91. PubMed ID: 22156391
[TBL] [Abstract][Full Text] [Related]
15. Rapalogs in cancer prevention: anti-aging or anticancer?
Blagosklonny MV
Cancer Biol Ther; 2012 Dec; 13(14):1349-54. PubMed ID: 23151465
[TBL] [Abstract][Full Text] [Related]
16. Association of PI3K-Akt signaling pathway with digitalis-induced hypertrophy of cardiac myocytes.
Liu L; Zhao X; Pierre SV; Askari A
Am J Physiol Cell Physiol; 2007 Nov; 293(5):C1489-97. PubMed ID: 17728397
[TBL] [Abstract][Full Text] [Related]
17. Strain-induced vascular endothelial cell proliferation requires PI3K-dependent mTOR-4E-BP1 signal pathway.
Li W; Sumpio BE
Am J Physiol Heart Circ Physiol; 2005 Apr; 288(4):H1591-7. PubMed ID: 15591103
[TBL] [Abstract][Full Text] [Related]
18. IL2-dependent phosphorylation of 40S ribosomal protein S6 is controlled by PI-3K/mTOR signalling in CTLL2 cells.
Tuhácková Z; Sloncová E; Vojtechová M; Sovová V
Int J Mol Med; 2004 Apr; 13(4):601-5. PubMed ID: 15010863
[TBL] [Abstract][Full Text] [Related]
19. Cell signaling. Aging is RSKy business.
Kaeberlein M; Kapahi P
Science; 2009 Oct; 326(5949):55-6. PubMed ID: 19797648
[No Abstract] [Full Text] [Related]
20. Oncogenic tyrosine kinase NPM/ALK induces activation of the rapamycin-sensitive mTOR signaling pathway.
Marzec M; Kasprzycka M; Liu X; El-Salem M; Halasa K; Raghunath PN; Bucki R; Wlodarski P; Wasik MA
Oncogene; 2007 Aug; 26(38):5606-14. PubMed ID: 17353907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
